ea0063p586 | Diabetes, Obesity and Metabolism 2 | ECE2019
Cook Keziah
, Stears Anna
, Araujo-Vilar David
, Santini Ferruccio
, O'Rahilly Stephen
, Ceccarini Giovanni
, Tibrewala Shruti
, Bradt Pamela
, Vigouroux Corinne
, Vatier Camille
, Savage David B
Objective: To evaluate the real-world experience of patients with generalized (GL) and partial (PL) lipodystrophy initiating treatment with metreleptin as part of an early access program (EAP).Methods: A retrospective data collection was conducted from four countries for patients enrolled in the EAP. A descriptive analysis was performed on selected patient characteristics, baseline organ impairments and complications, and response to metreleptin therapy,...